Literature DB >> 12913732

Renal angiomyolipoma associated with rapid enlargement [correction of enlargment] and inferior vena caval tumor thrombus.

Xavier Gamé1, Michel Soulié, Sidi Moussouni, Daniel Roux, Ghislaine Escourrou, Christine Chevreau, Richard Aziza.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12913732     DOI： 10.1097/01.ju.0000074709.64318.5c

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Renal epithelioid angiomyolipoma: MRI findings.

Authors:  Yan Zhong; Yanguang Shen; Jingjing Pan; Yingwei Wang; Yunxia An; Aitao Guo; Lu Ma; Huiyi Ye; Haiyi Wang
Journal:  Radiol Med       Date:  2017-07-10       Impact factor: 3.469

2.  [Bilateral renal angiomyolipomas with a thrombus in the inferior caval vein. Rare growth pattern of a benign tumor].

Authors:  S Bierer; C Wülfing; M-E Bode; G Pühse; O-A Brinkmann; L Hertle
Journal:  Urologe A       Date:  2005-12       Impact factor: 0.639

3.  Renal angiomyolipoma associated with inferior vena cava thrombus.

Authors:  Xavier Durand; Raphaelle Renard-Penna; Eva Comperat; Marc-Olivier Bitker; Francois Richard
Journal:  Case Rep Med       Date:  2009-12-16

4.  Renal epithelioid angiomyolipoma: a rare variant with unusual behavior.

Authors:  Mohammed Hassan; Ahmed S El-Hefnawy; Ahmed M Elshal; Ahmed Mosbah; Mahmoud El-Baz; Attalah Shaaban
Journal:  Int Urol Nephrol       Date:  2013-08-09       Impact factor: 2.370

5.  Nephron sparing surgery for renal angiomyolipoma with inferior vena cava thrombus in tuberous sclerosis.

Authors:  Adrien Riviere; Thomas Bessede; Jean-Jacques Patard
Journal:  Case Rep Urol       Date:  2014-02-23

6.  ♣Evaluation of clinicopathological profiles and development of a risk model in renal epithelioid angiomyolipoma patients: a large-scale retrospective cohort study.

Authors:  Aihetaimujiang Anwaier; Wen-Hao Xu; Xi Tian; Tao Ding; Jia-Qi Su; Yue Wang; Yuan-Yuan Qu; Hai-Liang Zhang; Ding-Wei Ye
Journal:  BMC Urol       Date:  2022-09-12       Impact factor: 2.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.